Benitec Biopharma (BNTC) Current Leases (2020 - 2025)

Benitec Biopharma (BNTC) reported Current Leases of $468000.0 for Q4 2025, up 13.04% sequentially from $414000.0 in Q3 2025.

Benitec Biopharma (BNTC) Current Leases (2020 - 2025) Analysis & Trends

Benitec Biopharma (BNTC) has 6 years of Current Leases data on file, last reported at $468000.0 in Q4 2025.

For the quarter ending Q4 2025, Current Leases changed N/A year-over-year to $468000.0; the trailing twelve-month figure through Dec 2025 stood at $468000.0 (changed N/A YoY), and the FY2025 full-year result was $354000.0, up 24.65% from the prior year.
Current Leases grew to $468000.0 in Q4 2025, from $414000.0 in the prior quarter.
In the past five years, Current Leases ranged from a high of $468000.0 in Q4 2025 to a low of $194000.0 in Q3 2021.
A 5-year average of $279578.9 and a median of $269000.0 in 2023 frame the typical range for Current Leases.
Across the five-year window, Current Leases slipped 24.64% in 2024 and soared 96.21% in 2025, its largest moves.
Tracing BNTC's Current Leases over 5 years: stood at $213000.0 in 2021, then grew by 23.47% to $263000.0 in 2022, then climbed by 8.75% to $286000.0 in 2023, then declined by 26.22% to $211000.0 in 2024, then surged by 121.8% to $468000.0 in 2025.
Business Quant data shows BNTC's Current Leases at $468000.0 in Q4 2025, $414000.0 in Q3 2025, and $354000.0 in Q2 2025.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Current Leases (Qtr)
1	Oculis Holding AG	68,785.72 Bn	68,785.72 Bn	-	531,233.95
2	Nanobiotix	1,895.57 Bn	1,895.51 Bn	-	-
3	BeOne Medicines	471.35 Bn	466.56 Bn	1.35 Bn	20.58 Mn
4	NuCana	279.75 Bn	279.75 Bn	-	872,589.03
5	Vertex Pharmaceuticals	120.24 Bn	113.00 Bn	2.59 Bn	-
6	Regeneron Pharmaceuticals	67.80 Bn	59.04 Bn	3.31 Bn	720.00 Mn
7	Belite Bio	62.51 Bn	62.51 Bn	-	-
8	Argenx Se	57.38 Bn	57.38 Bn	1.41 Bn	11.00 Mn
9	Revolution Medicines	37.78 Bn	37.78 Bn	-	16.61 Mn
10	Benitec Biopharma	46.45 Mn	46.45 Mn	-	468,000.00

Download Data